» Articles » PMID: 18790623

New Injectors and the Social Context of Injection Initiation

Overview
Publisher Elsevier
Date 2008 Sep 16
PMID 18790623
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preventing the onset of injecting drug use is an important public health objective yet there is little understanding of the process that leads to injection initiation. This paper draws extensively on narrative data to describe how injection initiation is influenced by social environment. We examine how watching other people inject can habitualise non-injectors to administering drugs with a needle and consider the process by which the stigma of injecting is replaced with curiosity.

Method: In-depth interviews (n=54) were conducted as part of a 2-year longitudinal study examining the behaviours of new injecting drug users.

Results: Among our sample, injection initiation was the result of a dynamic process during which administering drugs with a needle became acceptable or even appealing. Most often, this occurred as a result of spending time with current injectors in a social context and the majority of this study's participants were given their first shot by a friend or sexual partner. Initiates could be tenacious in their efforts to acquire an injection trainer and findings suggest that once injecting had been introduced to a drug-using network, it was likely to spread throughout the group.

Conclusion: Injection initiation should be viewed as a communicable process. New injectors are unlikely to have experienced the negative effects of injecting and may facilitate the initiation of their drug-using friends. Prevention messages should therefore aim to find innovative ways of targeting beginning injectors and present a realistic appraisal of the long-term consequences of injecting. Interventionists should also work with current injectors to develop strategies to refuse requests from non-injectors for their help to initiate.

Citing Articles

First-line opioid agonist treatment as prevention against assisting others in initiating injection drug use: A longitudinal cohort study of people who inject drugs in Vancouver, Canada.

Bouck Z, Tricco A, Rosella L, Banack H, Fox M, Platt R Drug Alcohol Depend Rep. 2023; 7:100168.

PMID: 37397436 PMC: 10311194. DOI: 10.1016/j.dadr.2023.100168.


U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.

Bennett A, Guarino H, Britton P, OBrien-Mazza D, Cook S, Taveras F Ann Med. 2022; 54(1):1826-1838.

PMID: 35792749 PMC: 9262363. DOI: 10.1080/07853890.2022.2092896.


Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey.

Oguya F, Kenya P, Ongecha F, Mureithi P, Musyoka H, Muraguri N BMC Public Health. 2021; 21(1):1549.

PMID: 34391389 PMC: 8364050. DOI: 10.1186/s12889-021-11373-9.


Factors Associated with Likelihood of Initiating Others into Injection Drug Use Among People Who Inject Drugs in West Virginia.

Allen S, Schneider K, Mazhnaya A, White R, ORourke A, Kral A AIDS Behav. 2021; 26(1):47-56.

PMID: 34076812 PMC: 8170059. DOI: 10.1007/s10461-021-03325-6.


Geographic Differences and Social Determinants of Health Among People With HIV Attributed to Injection Drug Use, United States, 2017.

Jin C, Nwangwu-Ike N, Gant Z, Johnson Lyons S, Satcher Johnson A Public Health Rep. 2021; 137(3):525-536.

PMID: 33882743 PMC: 9109533. DOI: 10.1177/00333549211007168.


References
1.
Scott G . "They got their program, and I got mine": a cautionary tale concerning the ethical implications of using respondent-driven sampling to study injection drug users. Int J Drug Policy. 2008; 19(1):42-51. DOI: 10.1016/j.drugpo.2007.11.014. View

2.
Darke S . Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51(3):253-63; discussion 267-8. DOI: 10.1016/s0376-8716(98)00028-3. View

3.
Frank B . An overview of heroin trends in New York City: past, present and future. Mt Sinai J Med. 2000; 67(5-6):340-6. View

4.
Thorpe L, Ouellet L, Levy J, Williams I, Monterroso E . Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis. 2000; 182(6):1588-94. DOI: 10.1086/317607. View

5.
Chitwood D, Sanchez J, Comerford M, Page J, McBride D, Kitner K . First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care. 2000; 12(3):313-20. DOI: 10.1080/09540120050042972. View